Journal Information
Vol. 35. Issue 11.
Pages 567-570 (December 1999)
Share
Share
Download PDF
More article options
Vol. 35. Issue 11.
Pages 567-570 (December 1999)
Full text access
Mutación 20210G/A del gen de la protrombina en un paciente con trombosis venosa profunda y embolia pulmonar sin otros factores de riesgo trombótico
202106/A mutation of the prothrombin gene in a patient with deep venous thrombosis and pulmonary embolism with no further risk factors for thrombosis
Visits
8116
P. de la Cuadra*,1, M.D. Nauffal*, A. Vayá Montaña**, M.A. Martínez*, M. Perpiñá*
* Servicio de Neumología, Laboratorio de Biopatología Clínica. Hospital Universitario La Fe. Valencia
** Unidad de Hemostasia, Laboratorio de Biopatología Clínica. Hospital Universitario La Fe. Valencia
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics

En 1996 se describió una nueva anomalía genética predisponente a la trombosis venosa: la sustitución de guanina (G) por adenina (A) en la posición 20210 de la región 3’-UT del gen de la protrombina. Esta anomalía se asocia con la elevación de los valores plasmáticos de protrombina y con un incremento del riesgo de aparición de fenómenos trombóticos en el sistema venoso.

Presentamos el caso de un paciente que, en ausencia de factores de riesgo trombótico conocidos, sufrió una embolia pulmonar masiva y una trombosis venosa profunda en ambas extremidades inferiores. En el estudio de trombofilia practicado, se constató que el paciente y tres familiares de primer grado eran portadores de la variante heterozigota 20210G/A del gen de la protrombina. Dos de los familiares portadores del defecto genético habían padecido algún episodio de trombosis venosa profunda con anterioridad.

Palabras clave:
Enfermedad tromboembólica venosa
Gen de la protrombina
Trombofilia familiar

A new genetic anomaly predisposing to venous thrombosis was described in 1996, namely the transition of guanine (G) to adenine (A) at position 20210 in the 3 -untranslated region of the prothrombin gene. This mutation is associated with high leveis of plasma prothrombin and increased risk of thrombotic events in the venous system.

We report the case of a man who, lacking known risk factors for thrombosis, suffered a massive pulmonary embolism and deep venous thrombosis in both lower legs. Thrombophilic analysis confirmed that the patient and close relatives were carriers of the heterozygotic 20210G/A variant of the prothrombin gene. Two relatives with the genetic defect had aiso suffered some type of deep venous thrombosis.

Key words:
Venous thromhoembolic disease
Prothrombin gene
Familial thrombophilia
Full text is only aviable in PDF
Bibliografía
[1.]
S.R. Poort, F.R. Rosendaal, P.H. Reitsma, R.M. Bertina.
A Common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.
Blood, 88 (1996), pp. 3.698-3.703
[2.]
A.M. Cumming, S. Keeney, A. Salden, M. Bhavnani, K.H. Shwe, R.M. Hay.
The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population.
Br J Haematol, 98 (1997), pp. 353-355
[3.]
B. Dahlbiick, M. Carlsson, P.J. Svenson.
Familial trombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
Proc Nati Acad Sci USA, 90 (1993), pp. 1.004-1.008
[4.]
R.M. Bertina, P.C. Koeleman, T. Koster, F.R. Rosendaal, R.J. Dirven, H. De Ronde, et al.
Mutation in blood coagulation factor V associated with resistance to activated protein C.
Nature, 369 (1994), pp. 64-67
[5.]
A. Hillarp, B. Zoller, P.J. Svensson, B. Dahlbiick.
The 20210 A allele of the prothrombin gene is a common risk factor among swedish outpatients with verified deep venous thrombosis.
Thronib Haemost, 79 (1997), pp. 990-992
[6.]
P. Ferraresi, G. Marchetti, C. Legnani, E. Cavallari, E. Castoldi, F. Mascoli, et al.
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frecuency in artery disease.
Arterioscler Thromb Vasc Biol, 17 (1997), pp. 2.418-2.422
[7.]
R.K. Kapur, L.A. Mills, S.G. Spitzer, M.B. Hultin.
A prothrombin gene mutation is significantly associated with venous thrombosis.
Arterioscler Thromb Vasc Biol, 17 (1997), pp. 2.875-2.879
[8.]
M. Makris, F.E. Preston, N.J. Beauchamp, P.C. Cooper, M.E. Daly, K.K. Hampton, et al.
Coinheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjeets with familial thrombophilia.
Thromb Haemost, 78 (1997), pp. 1.426-1.429
[9.]
K. Brown, R. Luddington, D. Williamson, P. Baker, T. Baglin.
Risk of venous thromboembolism associated with G to A transition at position 20210 in the 3 -untranslated region of the prothrombin gene.
Br J Haematol, 98 (1997), pp. 907-909
[10.]
V.R. Arruda, J.M. Annichino-Bizzacchi, M.S. Gongalvez, F.F. Costa.
Prevalence of the prothrombin gene variant (nt202!0A) in venous thrombosis and arterial disease.
Thromb Haemost, 78 (1997), pp. 1.430-1.433
[11.]
J. Corral, R. González-Conejero, M.L. Lozano, J. Rivera, I. Heras, V. Vívente.
The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease.
Br J Haematol, 99 (1997), pp. 304-307
[12.]
S. Ehrenforth, G. Ludwig, S. Klinke, M. Krause, I. Seharrer, U. Nowak-Göttl.
The prothrombin 20210A allele is frequently coinherited in young carriers of the factor V Arg 506 to Gln mutation with venous thrombophilia.
Blood, 91 (1998), pp. 2.209-2.210
[13.]
J. Conard, C. Mabileau-Brouzes, M.H. Horellou, I. Elalamy, M.M. Samama.
Thrombophilie multigénique: anomalie génétique du facteur II et mutation du facteur V Leiden.
Étude dans une famille française. Presse Med, 26 (1997), pp. 951-953
[14.]
C.J.M. Doggen, V.M. Cats, R.M. Bertina, F.R. Rosendaal.
Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A.
Circulation, 97 (1998), pp. 1.037-1.041
[15.]
B. Zöller, P.J. Svensson, B. Dahlbäck, A. Hillarp.
The A20210 allele of the prothrombin gene is frequently associated with the factor V ARg 506 to Gln mutation but not with protein S deficieney in thrombophilie families.
Blood, 91 (1998), pp. 2.210-2.211
[16.]
F.R. Rosendaal, D.S. Siscovick, S.M. Schwartz, B.M. Psaty, T.E. Ragnunathan, H.L. Vos.
A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young woman.
Blood, 90 (1997), pp. 1.747-1.750
[17.]
I. Martinelli, F. Franchi, S. Akwan, P. Bettini, G. Merati, P.M. Manucci.
The transition G to A at position 20210 in the 3’-untranslaled región of the prothrombin gene is not associated with cerebral ischemia.
Blood, 90 (1997), pp. 3.806-3.811
[18.]
M.C. Rahimy, R. Krishnamoorty, G. Ahouignan, M. Laffan, T. Vulliamy.
The 20210A allele of prothrombin is not found among sickle cell disease..
Thromb Haemost, 79 (1998), pp. 444-445
Copyright © 1999. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?